FI934895A7 - Antiarytmisia, aryylifuusioituja ja hetaryylifuusioituja 2,4-diatsepiini- ja 2,4-diatsosiiniyhdisteitä - Google Patents

Antiarytmisia, aryylifuusioituja ja hetaryylifuusioituja 2,4-diatsepiini- ja 2,4-diatsosiiniyhdisteitä Download PDF

Info

Publication number
FI934895A7
FI934895A7 FI934895A FI934895A FI934895A7 FI 934895 A7 FI934895 A7 FI 934895A7 FI 934895 A FI934895 A FI 934895A FI 934895 A FI934895 A FI 934895A FI 934895 A7 FI934895 A7 FI 934895A7
Authority
FI
Finland
Prior art keywords
fused
hetaryl
diazepine
antiarrhythmic
aryl
Prior art date
Application number
FI934895A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI934895A0 (fi
FI934895L (fi
Inventor
Donald Charles Schlegel
Alan Mark Ezrin
Robert Ed Johnson
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI934895A0 publication Critical patent/FI934895A0/fi
Publication of FI934895A7 publication Critical patent/FI934895A7/fi
Publication of FI934895L publication Critical patent/FI934895L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D245/00Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
FI934895A 1992-11-10 1993-11-05 Antiarrytmiska, arylfusionerade och hetarylfusionerade 2,4-diazepin- och 2,4-diazocin foereningar FI934895L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97439692A 1992-11-10 1992-11-10
US2192693A 1993-02-24 1993-02-24

Publications (3)

Publication Number Publication Date
FI934895A0 FI934895A0 (fi) 1993-11-05
FI934895A7 true FI934895A7 (fi) 1994-05-11
FI934895L FI934895L (fi) 1994-05-11

Family

ID=26695257

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934895A FI934895L (fi) 1992-11-10 1993-11-05 Antiarrytmiska, arylfusionerade och hetarylfusionerade 2,4-diazepin- och 2,4-diazocin foereningar

Country Status (15)

Country Link
EP (1) EP0597540B1 (Direct)
JP (1) JPH06220025A (Direct)
AT (1) ATE138916T1 (Direct)
AU (1) AU4472093A (Direct)
CA (1) CA2104060A1 (Direct)
CZ (1) CZ237393A3 (Direct)
DE (1) DE69302991D1 (Direct)
FI (1) FI934895L (Direct)
HU (1) HUT67281A (Direct)
IL (1) IL107519A0 (Direct)
MX (1) MX9305312A (Direct)
NO (1) NO934058D0 (Direct)
NZ (1) NZ248414A (Direct)
SK (1) SK124593A3 (Direct)
TW (1) TW245714B (Direct)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE478070T1 (de) * 2005-10-27 2010-09-15 Schering Corp Heterozyklische aspartyl-proteasehemmer
WO2010019417A2 (en) * 2008-08-13 2010-02-18 Boehringer Ingelheim International Gmbh Chymase inhibitors
US20130116241A1 (en) 2011-11-09 2013-05-09 Abbvie Inc. Novel inhibitor compounds of phosphodiesterase type 10a
KR101991429B1 (ko) 2014-12-19 2019-06-20 주식회사 엘지화학 새로운 화합물 및 이를 이용한 고분자 전해질막
CN113840820B (zh) * 2019-05-29 2024-05-03 St制药株式会社 酞嗪酮化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH527828A (de) * 1967-04-13 1972-09-15 Ciba Geigy Ag Verfahren zur Herstellung von 2,4-Benzdiazepinen
US3696093A (en) * 1970-09-30 1972-10-03 Ciba Geigy Corp 2,4-benzodiazepines
NZ232396A (en) * 1989-02-10 1991-07-26 Merrell Dow Pharma 2-(diphenylalkylamino) -1,3 nn heterocyclic compounds and pharmaceutical compositions
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
TW245719B (Direct) * 1990-09-10 1995-04-21 Sterling Winthrop Inc

Also Published As

Publication number Publication date
FI934895A0 (fi) 1993-11-05
IL107519A0 (en) 1994-02-27
EP0597540A1 (en) 1994-05-18
DE69302991D1 (de) 1996-07-11
NO934058D0 (no) 1993-11-09
CA2104060A1 (en) 1994-05-11
CZ237393A3 (en) 1996-08-14
TW245714B (Direct) 1995-04-21
SK124593A3 (en) 1994-08-10
AU4472093A (en) 1994-05-26
MX9305312A (es) 1995-01-31
NO934058L (Direct) 1994-05-11
ATE138916T1 (de) 1996-06-15
EP0597540B1 (en) 1996-06-05
NZ248414A (en) 1995-02-24
HUT67281A (en) 1995-03-28
JPH06220025A (ja) 1994-08-09
HU9303135D0 (en) 1994-02-28
FI934895L (fi) 1994-05-11

Similar Documents

Publication Publication Date Title
FI931560A7 (fi) Anordning foer installering av en flexibel ledning omfattande en kroekningsbegraensare
FI940218A0 (fi) Antiparasiittisia aineita
FI924534A7 (fi) Komposter
FI931603L (fi) Foerfarande foer framstaellning av bifenylderivat
DE69304334D1 (de) L-klasse schmelzsicherung
DE69218380D1 (de) Streugerät
FI933151L (fi) 5,10 metylentetrahydrofolsyre-cyklodextrin-inneslutningsfoereningar
LV10958A (lv) Aizvietotie 6- azaandrostenoni
FI934748L (fi) Foerfarande foer framstaellning av L-5-(2-acetoxipropionylamino)-2,4,6-trijod-isoftalsyradiklorid
NO930926D0 (no) 2-oksokinolinderivater
NO932842D0 (no) 1,4-benzodioksanderivater
FI931459L (fi) Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
DE59308564D1 (de) 2,4-Dialkyl-6-sec-alkylphenole
FI934895A7 (fi) Antiarytmisia, aryylifuusioituja ja hetaryylifuusioituja 2,4-diatsepiini- ja 2,4-diatsosiiniyhdisteitä
FI934928A7 (fi) Foerfarande foer framstaellning av 3,7-dialkylxantiner fraon 3-alkylxantiner
FI934624A0 (fi) Enantiomera cis-3-(4,6-dihydroxikroman-3-ylmetyl)bensoesyror
FI933605A0 (fi) Sammansaettningar av 1-klor-2,2,2-trifluoretyldifluormetyleter och partiellt fluorerade alkanoler
FI932396A7 (fi) Foerfarande foer framstaellning av en dubbelskyddad 2,3-hydroximetylcyklobutanol
FI951760L (fi) Gestageenisesti vaikuttavat 19,11-silloitetut 4-estreenit
FI930237L (fi) Foerfarande foer framstaellning av 4,6-dialkoxipyrimidiner
FI94U1 (fi) Kompostor
FI934081L (fi) Foerfarande foer framstaellning av N-hydroxi-N'-diazeniumoxider
FI933872A7 (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4H)-on-derivat
FI933290A0 (fi) 21-klorpregnanderivat
ITCT920024A0 (it) Denti-salva 1

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SANOFI

FD Application lapsed
FD Application lapsed